NP47924 Cytokine Modulators

Description

Supply of Cytokine Modulators to NHS Scotland. Lot 1: Etanercept Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Lot 2: Infliximab IV Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants. Lot 3: Infliximab SC Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Lot 4: Methotrexate syringes (25mg/1 ml concentration) Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Lot 5: Methotrexate pens (25mg/1ml concentration) Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Lot 6: Methotrexate pens (50mg/1 ml concentration) Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Lot 7: Methotrexate syringes (50mg/1ml concentration) Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.